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General anesthesiaAbstract Objective: This randomized, double blind, controlled study was designed to test whether
the intraoperative use of intravenous lidocaine bolus followed by infusion would attenuate the
tourniquet induced hypertension (TIH) in patients undergoing anterior cruciate ligament recon-
struction (ACLR) under general anesthesia.
Methods: 76 patients were randomly allocated into two equal groups. Lidocaine group (group L), in
which patients received lidocaine 2% 1 mg/kg IV bolus after induction of anesthesia followed by lido-
caine infusion (2 mg/kg/h) and placebo group (group P), in which patients received equal volumes of
saline. Heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP) were
recorded before induction of anesthesia, before tourniquet inflation (baseline value), every 15 min
after tourniquet inflation, and after tourniquet deflation. The number of patients who developed
TIH was recorded and total amount of propofol and fentanyl used intraoperative was recorded.
Results: SBP, DBP and HR were significantly less after tourniquet inflation in group L compared to
group P inmost of the time periods after tourniquet inflation (p value < 0.05), the number of patients
developed TIH was significantly less in group L compared to group P (26% in group L compared to
52.6% in group P) (p value 0.019), and the total amount of propofol and fentanyl used intraoperative
was significantly less in group L compared to group P (p value 0.000).
Conclusion: Intraoperative use of lidocaine bolus (1 mg/kg), followed by infusion (2 mg/kg/h),
started 10 min before tourniquet inflation attenuated the TIH in patients undergoing anterior cruciate
ligament reconstruction under general anesthesia.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Arterial tourniquet is used in limb surgeries to provide a
bloodless field and improve the surgical conditions. However,
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may be relatively benign in healthy individuals, but could be
hazardous in patients with impaired cardiac conditions [1].
Tourniquet inflation is associated with an increased sympa-
thetic outflow, an increase in arterial blood pressure and severe
pain [2–4].
The tourniquet induced hypertension (TIH) is usually
delayed 30–60 min after tourniquet inflation [5], and it is diffi-
cult to treat even with adequate analgesia and good level of
anesthesia [6,7]. Although the proper mechanism of (TIH) is
still unclear [7], the autonomic nervous system is probably
involved and plasma catecholamine levels are increased [2].
Also, stimulation of N-methyl-D-Aspartate (NMDA) recep-
tors by noxious stimuli from the extremities is another possible
cause leading to TIH [8,9]. There are several studies done using
different analgesics and NMDA receptor antagonists to find
an effective drug to attenuate (TIH) [6–8,5].
Intravenous lidocaine is known as having anti-
inflammatory [10,11], analgesic [10], anti-hyperalgesic [12]
properties and is used for attenuating stress response to laryn-
goscopy and intubation [13]. To our knowledge, no previous
studies tested the effect of intraoperative lidocaine infusion
on TIH.
We designed this randomized, double blind, placebo
controlled study to test whether the intraoperative use of intra-
venous lidocaine infusion would attenuate the TIH in patients
undergoing anterior cruciate ligament reconstruction under
general anesthesia as a primary outcome.2. Materials and methods
After obtaining ethical committee approval, written informed
consents were taken from 76 patients, American Society of
Anesthesiology (ASA) physical status I or II, their age range
between 18 and 50 years, who were scheduled for anterior
cruciate ligament reconstruction under general anesthesia with
the use of pneumatic tourniquet.
The study was carried out at Saad Specialist Hospital,
Alkhobar, Saudi Arabia, during the period from January
2014 to June 2015. Exclusion criteria included patients with
sickle cell disease, peripheral vascular disease, hypertension,
history of DVT, cardiac, liver or kidney diseases, allergy to
amide local anesthetics and seizure disorder. Patients weighing
more than 100 kg and patients in whom tourniquet time was
less than 60 min were also excluded.
Patients were randomly allocated into two equal groups
(37 patients each) by using the closed envelope technique.
The study drugs were prepared by an anesthesia technician
unaware of the study medications; as follows:
 Lidocaine group (group L): patients received lidocaine 2%
1 mg/kg IV bolus after induction of anesthesia followed by
lidocaine infusion (2 mg/kg/h) diluted in 50 ml syringe with
a maximum of 200 mg/h. The tourniquet was inflated
10 min after the start of lidocaine infusion. The lidocaine
infusion stopped at the time of tourniquet deflation.
 Placebo group (group P): equal volumes of saline.
Anesthesiologists, surgeons and patients were all blinded to
the treatment allocation. The lidocaine and placebo syringes
were identical and labeled as test medication. Anesthesiologistwho gave anesthesia was instructed not to use local
anesthetics.
Depending on previous studies [5,7], the sample size was
estimated to be 38 patients per group, to give a power of
80% at the level of 0.05 to detect 6.5% difference in the
percentage increase of baseline arterial blood pressure after
60 min of tourniquet inflation.
All patients were pre-medicated with midazolam 0.03 mg/kg
intravenously 5 min before induction of anesthesia. In the
operating room intravenous infusion of Ringer’s lactate
10 ml/kg started and monitors were attached to the patient
[ECG, pulse oximeter, non-invasive blood pressure, capnogra-
phy, temperature probe and bispectral index (BIS)]. Anesthesia
was induced using fentanyl 2 lg/kg IV, propofol 2 mg/kg IV
and cisatracurium 0.15 mg/kg IV to facilitate tracheal intuba-
tion. Mechanical ventilation was adjusted to maintain end
tidal CO2 between 35 and 40 mmHg. Anesthesia was main-
tained by using propofol infusion (5–10 mg/kg/h), starting
with (10 mg/kg/h) and then adjusted to maintain the BIS
between 40 and 60. Additional doses of fentanyl (50–100 lg)
were given if there were signs of inadequate analgesia (BP
and HR within 20% of pre-induction values). Cisatracurium
boluses of 0.03 mg/kg were guided by peripheral nerve stimu-
lator to maintain muscle relaxation.
If the BP or HR increased >30% of the baseline value
before tourniquet inflation, labetalol boluses of 5 mg were
given to control the hemodynamic changes.
The pneumatic tourniquet (20 cm width) was applied over
cotton layer to the upper thigh (operation side), the limb was
elevated 45 degrees for 5 min, exsanguination was done using
crepe bandage and the tourniquet was inflated to 300 mmHg.
The tourniquet was deflated at the end of the operation and
all anesthetics were discontinued.
Patients were extubated after reversal of neuromuscular
blockade using neostigmine 0.05 mg/kg and atropine
0.02 mg/kg IV and shifted to the post-anesthesia care unit
(PACU). The following parameters were recorded by an
anesthesiologist unaware of study drugs:
1. Hemodynamic including HR, SBP and DBP (measured
every 5 min) were recorded at the following time: before
induction of anesthesia, before tourniquet inflation (base-
line value), every 15 min after tourniquet inflation, and
15 min after tourniquet deflation.
2. The number of patients who developed TIH which was
defined by an increase in arterial blood pressure >30%
of the baseline value (number of patients received
labetalol).
3. Total dose of fentanyl needed intraoperative.
4. Total dose of propofol used intraoperatively.
5. Tourniquet time.
6. Duration of operation.2.1. The statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), or frequencies (number of cases) and
percentages when appropriate. Comparison of numerical vari-
ables between the study groups was done using Student’s t test
for independent samples while comparing variables over time
was done using repeated measure analysis of variance with
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comparing categorical data, Chi square (v2) test was
performed. Exact test was used instead when the expected fre-
quency is less than 5. p values less than 0.05 were considered
statistically significant. All statistical calculations were done
using computer program SPSS (Statistical Package for the
Social Science; SPSS Inc., Chicago, IL, USA) release 15 for
Microsoft Windows (2006).3. Results
All patients completed the study (Fig. 1).
Patients in both groups were comparable as regards demo-
graphic data, tourniquet time and duration of operation
(p value > 0.05), (Table 1). The total amount of fentanyl usedAssessment for e
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Table 1 Demographic data, operation time, total amount of fentan
Variables Group L (n= 38)
Age (years) 39.6 ± 12.3
Height (Cm) 169.5 ± 6.1
Weight (kg) 79.5 ± 2.8
Gender (male/female) 31/7
Tourniquet time (min) 85.9 ± 8.4
Operation time (min) 115.9 ± 12.5
Total amount of fentanyl (lg) 300 ± 40
Total amount of propofol (mg) 670 ± 77.0
TIH (n, %) 10 (26%)
Data are represented as mean ± SD, or number (%).
* p value < 0.05 is significant. TIH means tourniquet induced hypertenin group L was significantly less than that in group P (p value
0.000), and the total amount of propofol used was also signif-
icantly less in group L than in group P (p value 0.000) (Table 1).
The number of patients having TIH was significantly less in
group L compared to group P (p value 0.019) (Table1, Fig. 2).
Fig. 3 shows the changes in mean and SD in SBP between
both groups during the study period, the mean SBP was
significantly less after tourniquet inflation in the L group in
comparison with P group at 30, 45, 60 and 75 min
P value < 0.05, and also there was a significant difference in
the values of SBP after tourniquet inflation in group P in most
of the points and its baseline value, p value < 0.05.
Fig. 4 shows the mean DBP in both groups, DBP was sig-
nificantly less after tourniquet inflation in group L in compar-
ison with group P at 30, 45, 60 and 75 min, p value < 0.05, and
there was a significant difference in the values of DBP in bothlgibility 
6)
Excluded (n=0)
Allocated to intervenon(n=38)
Received allocaon to intervenon 
(n=38)
Did't receive allocaon to intervenon 
(n=0)
Lost to follow up (give reason) (n=0)
Analyse d (n=38) 
gram of the study groups.
yl and propofol and number of patients having TIH.
Group P (n= 38) P value
38.0 ± 10.9 0.550
170.0 ± 2.2 0.636
78.4 ± 2.5 0.079
30/8 1
87.6 ± 5.2 0.292
118.0 ± 10.0 0.421
420 ± 70 0.000*
815 ± 44.5 0.000*
20 (52.6%) 0.019*
sion.
Figure 2 Percentage of occurrence of TIH between the study
groups; * denotes p value is significant.
Figure 3 Mean and SD of SBP between the 2 groups (* denotes sign
to baseline value).
Figure 4 Mean and SD of DBP between the 2 groups (* denotes sign
to baseline value).
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measured after tourniquet inflation.
Fig. 5 shows the mean value and SD in heart rate in both
groups during the study period, the HR was significantly
higher in group P compared to group L at 45, 75 min after
tourniquet inflation and also after deflation of tourniquet
p value < 0.05, and both groups show significant difference
after tourniquet inflation from their baseline value
(p value < 0.05).
4. Discussion
Our study showed that the use of IV lidocaine bolus (1 mg/kg)
followed by infusion (2 mg/kg/h), 10 min before tourniquet
inflation and continued until tourniquet deflation resulted inificance between the 2 groups and # denotes significance compared
ificance between the 2 groups and # denotes significance compared
Figure 5 Mean and SD of HR between the 2 groups (* denotes significance between the 2 groups and # denotes significance compared to
baseline value).
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induced by pneumatic tourniquet inflation in patients undergo-
ing anterior cruciate ligament reconstruction under general
anesthesia. The incidence of TIH reduced from 52.6% in the
placebo group to 26% in the lidocaine group.
Although the mechanism of TIH is still not clear [7], two
mechanisms are thought to be involved; the first is activation
of C fibers, causing stimulation of NMDA receptors in the
dorsal horn of the spinal cord [7], and the second is sympa-
thetic activation [2].
Tetzlaff et al., demonstrated that TIH coincides with the
activation of the sympathetic nervous system, as shown by
power spectral analysis of heart rate [2]. This theory is sup-
ported by the finding that the onset of the TIH coincides with
the onset of tourniquet pain as both usually occur 30–60 min
after cuff inflation [14]. Heropoulos et al., reported an increase
in the plasma levels of catecholamines associated with TIH
under general anesthesia [15]. And, Zalunardo et al., showed
that preoperative administration of clonidine suppressed the
cardiovascular and hyperadrenergic response resulted from
tourniquet inflation [16].
The other hypothesis suggested that tourniquet pain is
mediated by unmyelinated, slow-conducting C fibers – which
are normally inhibited by fast pain impulses conducted by
myelinated A-d fibers – [17,18]. Mechanical compression
caused by tourniquet inflation leads to loss of conduction in
the large A-d fibers, leaving still functioning C fibers uninhib-
ited, that causes activation of NMDA receptors in the dorsal
horn of the spinal cord [7].
IV lidocaine injection blunts the sympathetic response in
many studies by attenuating the increase in BP, HR and cate-
cholamine release in response to intubation, extubation and
surgical stimulation [13,19,20].
The mechanism of analgesic effect of systemic lidocaine is
still poorly understood and is unlikely to be explained only
on the basis of lidocaine’s Na+ channel blocking effect [21].
Some research has suggested that it could be partly associated
with NMDA receptor antagonism by the glycinergic action oflidocaine itself or one of its metabolites [11,21]. Others sug-
gested the inhibition of G-protein-coupled receptors and the
inflammatory response possibly can contribute to the analgesia
seen with lidocaine infusions [22].
The observed attenuation of TIH by IV lidocaine injection
in this study could be explained by the effect of lidocaine on
sympathetic response and/or its systemic analgesic effect.
In our study, IV infusion of lidocaine resulted in less propo-
fol and fentanyl consumption, which is consistent with
previous studies that showed the sparing effect of systemic
lidocaine on anesthetic and opioid requirements and referred
this to anti-nociceptive effect of lidocaine [20,23].
The dose of bolus and the rate of infusion of lidocaine used
in our study were based on previous studies that proved that
this dose did not result in plasma concentration more than
4 mcg/ml, which is below the toxic levels [19,21].
We maintained an adequate level of anesthesia (BIS
between 40 and 60) by using propofol infusion, fentanyl
boluses to insure adequate analgesia and cisatracurium boluses
for muscle relaxation to exclude their inadequacy as factors
contributing to intraoperative hypertension and tachycardia.
Limitation in our study, we did not do dose response study
to the effect of lidocaine on TIH. Further studies are needed to
evaluate whether smaller doses of lidocaine bolus and infusion
can achieve the same benefit or whether larger doses can
reduce TIH to a greater extent.
5. Conclusion
Intraoperative use of lidocaine bolus (1 mg/kg), followed by
infusion (2 mg/kg/h), started 10 min before tourniquet
inflation attenuated the TIH in patients undergoing anterior
cruciate ligament reconstruction under general anesthesia.
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